Table 3 Clinicopathological features per S100+ DC infiltration
S100 Low (n = 29) | S100 High (n = 28) | P-value | |
|---|---|---|---|
Age, years (mean ± SD) | 68.4 ± 10.0 | 68.4 ± 7.6 | 0.995 |
Sex (%) | |||
Male | 28 (96.6%) | 26 (92.9%) | 0.532 |
Female | 1 (3.4%) | 2 (7.1%) | |
Subsite | |||
Glottic | 19 (65.5%) | 16 (57.1%) | 0.516 |
Supra/sub | 10 (34.5%) | 12 (42.9%) | |
Histology | |||
Well | 20 (69.0%) | 10 (35.7%) | 0.012 |
Mode/poor | 9 (31.0%) | 18 (64.3%) | |
T stage (%) | |||
T2/T3 | 12 (41.4%) | 14 (50.0%) | 0.514 |
T4 | 17 (58.6%) | 14 (50.0%) | |
N stage (%) | |||
N0 | 22 (75.9%) | 15 (53.6%) | 0.078 |
N1–3 | 7 (24.1%) | 13 (46.4%) | |
M stage (%) | |||
M0 | 28 (96.6%) | 28 (100.0%) | 0.322 |
M1 | 1 (3.4%) | 0 (0.0%) | |
Stage | |||
III | 11 (37.9%) | 9 (32.1%) | 0.647 |
IV | 18 (62.1%) | 19 (67.9%) | |
CD8+ CTLs | 499.2 ± 513.6 | 628.6 ± 498.2 | 0.541 |
Adjuvant therapy | |||
(−) | 11 (37.9%) | 8 (28.6%) | 0.454 |
(+) | 18 (62.1%) | 20 (71.4%) | |